CA199 (Fig. 2B) and CEA (Fig. 2C) levels in CRC patients increased with the increase of late stage, lymph node metastasis and tumor size ≥ 5 cm. This evidence concerns the gene CEACAM5 and metastatic malignant neoplasm in the lymph nodes.